-
1
-
-
0033581935
-
Selecting and maintaining a diverse T-cell repertoire
-
Goldrath, A.W., and M.J. Bevan. 1999. Selecting and maintaining a diverse T-cell repertoire. Nature. 402:255-262.
-
(1999)
Nature
, vol.402
, pp. 255-262
-
-
Goldrath, A.W.1
Bevan, M.J.2
-
2
-
-
0033491636
-
T lymphocyte tolerance: From thymic deletion to peripheral control mechanisms
-
Stockinger, B. 1999. T lymphocyte tolerance: from thymic deletion to peripheral control mechanisms. Adv. Immunol. 71:229-265.
-
(1999)
Adv. Immunol.
, vol.71
, pp. 229-265
-
-
Stockinger, B.1
-
3
-
-
0033607506
-
Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity
-
Bouillet, P., D. Metcalf, D.C. Huang, D.M. Tarlinton, T.W. Kay, F. Kontgen, J.M. Adams, and A. Strasser. 1999. Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science. 286:1735-1738.
-
(1999)
Science
, vol.286
, pp. 1735-1738
-
-
Bouillet, P.1
Metcalf, D.2
Huang, D.C.3
Tarlinton, D.M.4
Kay, T.W.5
Kontgen, F.6
Adams, J.M.7
Strasser, A.8
-
4
-
-
0037148840
-
BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes
-
Bouillet, P., J.F. Purton, D.I. Godfrey, L.C. Zhang, L. Coultas, H. Puthalakath, M. Pellegrini, S. Cory, J.M. Adams, and A. Strasser. 2002. BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes. Nature. 415:922-926.
-
(2002)
Nature
, vol.415
, pp. 922-926
-
-
Bouillet, P.1
Purton, J.F.2
Godfrey, D.I.3
Zhang, L.C.4
Coultas, L.5
Puthalakath, H.6
Pellegrini, M.7
Cory, S.8
Adams, J.M.9
Strasser, A.10
-
5
-
-
0037112047
-
Projection of an immunological self shadow within the thymus by the aire protein
-
Anderson, M.S., E.S. Venanzi, L. Klein, Z. Chen, S.P. Berzins, S.J. Turley, H. von Boehmer, R. Bronson, A. Dierich, C. Benoist, and D. Mathis. 2002. Projection of an immunological self shadow within the thymus by the aire protein. Science. 298:1395-1401.
-
(2002)
Science
, vol.298
, pp. 1395-1401
-
-
Anderson, M.S.1
Venanzi, E.S.2
Klein, L.3
Chen, Z.4
Berzins, S.P.5
Turley, S.J.6
Von Boehmer, H.7
Bronson, R.8
Dierich, A.9
Benoist, C.10
Mathis, D.11
-
6
-
-
0032482160
-
A role for Fas in negative selection of thymocytes in vivo
-
Kishimoto, H., C.D. Surh, and J. Sprent. 1998. A role for Fas in negative selection of thymocytes in vivo. J. Exp. Med. 187:1427-1438.
-
(1998)
J. Exp. Med.
, vol.187
, pp. 1427-1438
-
-
Kishimoto, H.1
Surh, C.D.2
Sprent, J.3
-
7
-
-
0029609086
-
Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis
-
Strasser, A., A.W. Harris, D.C. Huang, P.H. Krammer, and S. Cory. 1995. Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis. EMBO J. 14:6136-6147.
-
(1995)
EMBO J.
, vol.14
, pp. 6136-6147
-
-
Strasser, A.1
Harris, A.W.2
Huang, D.C.3
Krammer, P.H.4
Cory, S.5
-
8
-
-
0028807837
-
A role for the orphan steroid receptor Nur77 in apoptosis accompanying antigen-induced negative selection
-
Calnan, B.J., S. Szychowski, F.K. Chan, D. Cado, and A. Winoto. 1995. A role for the orphan steroid receptor Nur77 in apoptosis accompanying antigen-induced negative selection. Immunity. 3:273-282.
-
(1995)
Immunity
, vol.3
, pp. 273-282
-
-
Calnan, B.J.1
Szychowski, S.2
Chan, F.K.3
Cado, D.4
Winoto, A.5
-
10
-
-
0036794390
-
Deficiency in Bak and Bax perturbs thymic selection and lymphoid homeostasis
-
Rathmell, J.C., T. Lindsten, W.X. Zong, R.M. Cinalli, and C.B. Thompson. 2002. Deficiency in Bak and Bax perturbs thymic selection and lymphoid homeostasis. Nat. Immunol. 3:932-939.
-
(2002)
Nat. Immunol.
, vol.3
, pp. 932-939
-
-
Rathmell, J.C.1
Lindsten, T.2
Zong, W.X.3
Cinalli, R.M.4
Thompson, C.B.5
-
11
-
-
0036630358
-
The thymus and negative selection
-
Sprent, J., and H. Kishimoto. 2002. The thymus and negative selection. Immunol. Rev. 185:126-135.
-
(2002)
Immunol. Rev.
, vol.185
, pp. 126-135
-
-
Sprent, J.1
Kishimoto, H.2
-
12
-
-
0031883138
-
TNF receptor-deficient mice reveal striking differences between several models of thymocyte negative selection
-
Page, D.M., E.M. Roberts, J.J. Peschon, and S.M. Hedrick. 1998. TNF receptor-deficient mice reveal striking differences between several models of thymocyte negative selection. J. Immunol. 160:120-133.
-
(1998)
J. Immunol.
, vol.160
, pp. 120-133
-
-
Page, D.M.1
Roberts, E.M.2
Peschon, J.J.3
Hedrick, S.M.4
-
13
-
-
0035027854
-
DR3 regulates negative selection during thymocyte development
-
Wang, E.C., A. Thern, A. Denzel, J. Kitson, S.N. Farrow, and M.J. Owen. 2001. DR3 regulates negative selection during thymocyte development. Mol. Cell. Biol. 21:3451-3461.
-
(2001)
Mol. Cell. Biol.
, vol.21
, pp. 3451-3461
-
-
Wang, E.C.1
Thern, A.2
Denzel, A.3
Kitson, J.4
Farrow, S.N.5
Owen, M.J.6
-
14
-
-
0035500289
-
The critical role of LIGHT, a TNF family member, in T cell development
-
Wang, J., T. Chun, J. C. Lo, Q. Wu, Y. Wang, A. Foster, K. Roca, M. Chen, K. Tamada, L. Chen, et al. 2001. The critical role of LIGHT, a TNF family member, in T cell development. J. Immunol. 167:5099-5105.
-
(2001)
J. Immunol.
, vol.167
, pp. 5099-5105
-
-
Wang, J.1
Chun, T.2
Lo, J.C.3
Wu, Q.4
Wang, Y.5
Foster, A.6
Roca, K.7
Chen, M.8
Tamada, K.9
Chen, L.10
-
15
-
-
0034541174
-
The TNF receptor family member CD30 is not essential for negative selection
-
DeYoung, A.L., O. Duramad, and A. Winoto. 2000. The TNF receptor family member CD30 is not essential for negative selection. J. Immunol. 165:6170-6173.
-
(2000)
J. Immunol.
, vol.165
, pp. 6170-6173
-
-
DeYoung, A.L.1
Duramad, O.2
Winoto, A.3
-
16
-
-
0032472916
-
A dominant interfering mutant of FADD/MORT1 enhances deletion of autoreactive thymocytes and inhibits proliferation of mature T lymphocytes
-
Newton, K., A.W. Harris, M.L. Bath, K.G. Smith, and A. Strasser. 1998. A dominant interfering mutant of FADD/MORT1 enhances deletion of autoreactive thymocytes and inhibits proliferation of mature T lymphocytes. EMBO J. 17:706-718.
-
(1998)
EMBO J.
, vol.17
, pp. 706-718
-
-
Newton, K.1
Harris, A.W.2
Bath, M.L.3
Smith, K.G.4
Strasser, A.5
-
17
-
-
0029834497
-
CrmA expression in T lymphocytes of transgenic mice inhibits CD95 (Fas/APO-1)-transduced apoptosis, but does not cause lymphadenopathy or autoimmune disease
-
Smith, K.G., A. Strasser, and D.L. Vaux. 1996. CrmA expression in T lymphocytes of transgenic mice inhibits CD95 (Fas/APO-1)-transduced apoptosis, but does not cause lymphadenopathy or autoimmune disease. EMBO J. 15:5167-5176.
-
(1996)
EMBO J.
, vol.15
, pp. 5167-5176
-
-
Smith, K.G.1
Strasser, A.2
Vaux, D.L.3
-
18
-
-
0037338951
-
Defective thymocyte apoptosis and accelerated autoimmune diseases in TRAIL(-/-) mice
-
Lamhamedi-Cherradi, S.E., S.J. Zheng, K.A. Maguschak, J. Peschon, and Y.H. Chen. 2003. Defective thymocyte apoptosis and accelerated autoimmune diseases in TRAIL(-/-) mice. Nat. Immunol. 4:255-260.
-
(2003)
Nat. Immunol.
, vol.4
, pp. 255-260
-
-
Lamhamedi-Cherradi, S.E.1
Zheng, S.J.2
Maguschak, K.A.3
Peschon, J.4
Chen, Y.H.5
-
19
-
-
0035942230
-
Tumor necrosis factor-related apoptosis-inducing ligand in T cell development: Sensitivity of human thymocytes
-
Simon, A.K., O. Williams, J. Mongkolsapaya, B. Jin, X.N. Xu, H. Walczak, and G.R. Screaton. 2001. Tumor necrosis factor-related apoptosis-inducing ligand in T cell development: sensitivity of human thymocytes. Proc. Natl. Acad. Sci. USA. 98:5158-5163.
-
(2001)
Proc. Natl. Acad. Sci. USA
, vol.98
, pp. 5158-5163
-
-
Simon, A.K.1
Williams, O.2
Mongkolsapaya, J.3
Jin, B.4
Xu, X.N.5
Walczak, H.6
Screaton, G.R.7
-
20
-
-
0037342029
-
The suicide in the thymus, a twisted trail
-
Green, D.R. 2003. The suicide in the thymus, a twisted trail. Nat. Immunol. 4:207-208.
-
(2003)
Nat. Immunol.
, vol.4
, pp. 207-208
-
-
Green, D.R.1
-
21
-
-
0036467427
-
Increased susceptibility to tumor initiation and metastasis in TNF-related apoptosis-inducing ligand-deficient mice
-
Cretney, E., K. Takeda, H. Yagita, M. Glaccum, JJ. Peschon, and MJ. Smyth. 2002. Increased susceptibility to tumor initiation and metastasis in TNF-related apoptosis-inducing ligand-deficient mice. J. Immunol. 168:1356-1361.
-
(2002)
J. Immunol.
, vol.168
, pp. 1356-1361
-
-
Cretney, E.1
Takeda, K.2
Yagita, H.3
Glaccum, M.4
Peschon, J.J.5
Smyth, M.J.6
-
22
-
-
0033567099
-
Expression and function of TNF-related apoptosis-inducing ligand on murine activated NK cells
-
Kayagaki, N., N. Yamaguchi, M. Nakayama, K. Takeda, H. Akiba, H. Tsutsui, H. Okamura, K. Nakanishi, K. Okumura, and H. Yagita. 1999. Expression and function of TNF-related apoptosis-inducing ligand on murine activated NK cells. J. Immunol. 163:1906-1913.
-
(1999)
J. Immunol.
, vol.163
, pp. 1906-1913
-
-
Kayagaki, N.1
Yamaguchi, N.2
Nakayama, M.3
Takeda, K.4
Akiba, H.5
Tsutsui, H.6
Okamura, H.7
Nakanishi, K.8
Okumura, K.9
Yagita, H.10
-
23
-
-
0030659110
-
Antigen-specific and nonspecific deletion of immature cortical thymocytes caused by antigen injection
-
Martin, S., and M.J. Bevan. 1997. Antigen-specific and nonspecific deletion of immature cortical thymocytes caused by antigen injection. Eur. J. Immunol. 27:2726-2736.
-
(1997)
Eur. J. Immunol.
, vol.27
, pp. 2726-2736
-
-
Martin, S.1
Bevan, M.J.2
-
24
-
-
0037103223
-
Thymocyte apoptosis induced by T cell activation is mediated by glucocorticoids in vivo
-
Brewer, J.A., O. Kanagawa, B.P. Sleckman, and L.J. Muglia. 2002. Thymocyte apoptosis induced by T cell activation is mediated by glucocorticoids in vivo. J. Immunol. 169:1837-1843.
-
(2002)
J. Immunol.
, vol.169
, pp. 1837-1843
-
-
Brewer, J.A.1
Kanagawa, O.2
Sleckman, B.P.3
Muglia, L.J.4
-
25
-
-
0025818854
-
Timing of deletion of autoreactive V beta 6+ cells and down-modulation of either CD4 or CD8 on phenotypically distinct CD4+8+ subsets of thymocytes expressing intermediate or high levels of T cell receptor
-
Hugo, P., R.L. Boyd, G.A. Waanders, H.T. Petrie, and R. Scollay. 1991. Timing of deletion of autoreactive V beta 6+ cells and down-modulation of either CD4 or CD8 on phenotypically distinct CD4+8+ subsets of thymocytes expressing intermediate or high levels of T cell receptor. Int. Immunol. 3:265-272.
-
(1991)
Int. Immunol.
, vol.3
, pp. 265-272
-
-
Hugo, P.1
Boyd, R.L.2
Waanders, G.A.3
Petrie, H.T.4
Scollay, R.5
-
26
-
-
0025035509
-
T cell receptor-mediated negative selection of autoreactive T lymphocyte precursors occurs after commitment to the CD4 or CD8 lineages
-
Guidos, C.J., J.S. Danska, C.G. Fathman, and I.L. Weissman. 1990. T cell receptor-mediated negative selection of autoreactive T lymphocyte precursors occurs after commitment to the CD4 or CD8 lineages. J. Exp. Med. 172:835-845.
-
(1990)
J. Exp. Med.
, vol.172
, pp. 835-845
-
-
Guidos, C.J.1
Danska, J.S.2
Fathman, C.G.3
Weissman, I.L.4
-
27
-
-
0037383758
-
Aire regulates negative selection of organ-specific T cells
-
Liston, A., S. Lesage, J. Wilson, L. Peltonen, and C.C. Goodnow. 2003. Aire regulates negative selection of organ-specific T cells. Nat. Immunol. 4:350-354.
-
(2003)
Nat. Immunol.
, vol.4
, pp. 350-354
-
-
Liston, A.1
Lesage, S.2
Wilson, J.3
Peltonen, L.4
Goodnow, C.C.5
-
28
-
-
16944367194
-
Positional cloning of the APECED gene
-
Nagamine, K., P. Peterson, H.S. Scott, J. Kudoh, S. Minoshima, M. Heino, K.J. Krohn, M.D. Lalioti, P.E. Mullis, S.E. Antonarakis, et al. 1997. Positional cloning of the APECED gene. Nat. Genet. 17:393-398.
-
(1997)
Nat. Genet.
, vol.17
, pp. 393-398
-
-
Nagamine, K.1
Peterson, P.2
Scott, H.S.3
Kudoh, J.4
Minoshima, S.5
Heino, M.6
Krohn, K.J.7
Lalioti, M.D.8
Mullis, P.E.9
Antonarakis, S.E.10
-
29
-
-
0035863835
-
Roles of TNF-related apoptosis-inducing ligand in experimental autoimmune encephalomyetis
-
Hilliard, B., A. Wilmen, C. Seidel, T.S. Liu, R. Goke, and Y. Chen. 2001. Roles of TNF-related apoptosis-inducing ligand in experimental autoimmune encephalomyetis. J. Immunol. 166:1314-1319.
-
(2001)
J. Immunol.
, vol.166
, pp. 1314-1319
-
-
Hilliard, B.1
Wilmen, A.2
Seidel, C.3
Liu, T.S.4
Goke, R.5
Chen, Y.6
-
30
-
-
0034599757
-
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is an inhibitor of autoimmune inflammation and cell cycle progression
-
Song, K., Y. Chen, R. Goke, A. Wilmen, C. Seidel, A. Goke, and B. Hilliard. 2000. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is an inhibitor of autoimmune inflammation and cell cycle progression. J. Exp. Med. 191:1095-1104.
-
(2000)
J. Exp. Med.
, vol.191
, pp. 1095-1104
-
-
Song, K.1
Chen, Y.2
Goke, R.3
Wilmen, A.4
Seidel, C.5
Goke, A.6
Hilliard, B.7
|